Misonidazole and benznidazole inhibit hydroxylation of ccnu by mouse liver microsomal cytochrome P-450 in vitro
- 31 March 1987
- journal article
- research article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 36 (8), 1349-1355
- https://doi.org/10.1016/0006-2952(87)90093-1
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- A phase I study of the combination of benznidazole and CCNU in manInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Modification of chemotherapy by nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Misonidazole and CCNU: Further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gainBritish Journal of Cancer, 1984
- Chemosensitization by lipophilic nitroimidazolesBritish Journal of Cancer, 1983
- Modification of CCNU pharmacokinetics by misonidazole—a major mechanism of chemosensitization in miceBritish Journal of Cancer, 1983
- Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNUBritish Journal of Cancer, 1982
- Potentiation of chemotherapy by hypoxic cell radiation sensitizers—A reviewInternational Journal of Radiation Oncology*Biology*Physics, 1982
- The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazolesInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Enhancement of chemotherapy agentsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- A review of hypoxic cell radiosensitization in experimental tumorsPharmacology & Therapeutics, 1979